Surgery – Means for introducing or removing material from body for... – Material introduced into and removed from body through...
Patent
1994-08-26
1998-12-29
Coggins, Wynn Wood
Surgery
Means for introducing or removing material from body for...
Material introduced into and removed from body through...
604 57, 604 93, 424 9321, A61M 3100
Patent
active
058533850
ABSTRACT:
This invention relates to implantation of encapsulated PC12 cells capable of slowing or preventing the degenerative processes of Parkinson's disease by releasing factors in addition to dopamine into individuals suffering from the disease. This restorative effect continues even after the encapsulated cells are removed from the patient's brain.
REFERENCES:
patent: 5750103 (1998-05-01), Chaksey
Aebischer, Patrick, et al., "Functional Recovery in Hemiparkinsonian Primates Transplanted with Polymer-Encapsulated PC12 Cells," 126, Experimental Neurology, pp. 151-158 (1994).
Aebischer, Patrick, et al., "Long-Term Cross-Species Brain Transplantation of a Polymer-Encapsulated Dopamine-Secreting Cell Line," 111, Experimental Neurology, pp. 269-275 (1991).
Aesbsicher, Patrick, et al., "Macroencapsulation of Dopamine-Secreting Cells by Coextrusion With An Organic Polymer Solution," 12, Biomaterials, pp. 50-56 (1991).
Aesbicher, Patrick, et al., "Transplantation of Polymer Encapsulated Neurotransmitter Secreting Cells: Effect of the Encapsulation Technique," 113, Journal of Biomechanical Engineering, pp. 178-183 (1991).
Bakay, R.A.E., et al., "Biochemical And Behavioral Correction Of MPTP-Like Syndrome By Fetal Cell Transplantation", Ann. NY Acad. Sci., 495, pp. 623-640 (1987).
Bankiewiez, K.S., et al., "Transient Behavioral Recovery In Hemiparkinsonian Primates After Adrenal Medullary Allografts", Progress in Brain Research, 78, pp. 543-550 (1988).
Bing, G., et al., "Comparison Of Adrenal Medullary, Carotid Body And PC12 Cell Grafts In 6-OHDA Lesioned Rats", Brain Res. Bull., 20, pp. 399-406 (1988).
Cabasso, I., "Hollow Fiber Membranes," 12, Encyclopedia of Chemical Technology, 3rd Ed. Wiley, New York, (Kirk-Othmer, ed.), pp. 492-517 (1980).
Christenson, L., et al., "Tissue Reaction To Intraperitoneal Polymer Implants: Species Difference and Effects of Corticoid and Doxorubicin," J. Biomed. Mat. Res., 23, pp. 705-718 (1989).
Christenson, L., "Polymer Encapsulated Thymic Stromal Tissue: Biocompatibility, Procurement and Functional Studies," Ph.D. thesis, Brown University, (1990).
Emerich, D.F., et al., "A Novel Approach To Neural Transplantation In Parkinson's Disease: Use Of Polymer-Encapsulated Cell Therapy", Neurosci. Biobehav. Rev., 16, pp. 437-447 (1992).
Emerich, D.F., et al., "Polymer-Encapsulated PC12 Cells Promote Recovery of Motor Function in Aged Rats," 122, Experimental Neurology, pp.37-47 (1993).
Emerich, D.F., et al., "Transplanation of Polymer Encapsulated PC12 Cells: Use of Chitosan as an Immobilization Matrix," 2, Cell Transplantation, pp. 241-249 (1993).
Freed, C.R., et al., "Survival Of Implanted Fetal Dopamine Cells And Neurologic Improvement 12 to 46 Months After Transplantation For Parkinson's Disease", New England Journal of Medicine, 327, pp. 1549-1555 (1992).
Greene, L.A., and A.S. Tischler, "Establishment Of A Noradrenergic Clonal Line Of Rat Adrenal Pheochromocytoma Cells Which Respond To Nerve Growth Factor", Proc. Natl. Acad. Sci. USA, 73, pp. 2424-2428 (1976).
Grulke, Eric A., "Solubility Parameter Values," Polymer Handbook 3rd Ed., John Wiley & Sons, NY (J. Brandrup and E.H. Immergut, eds.), pp. 519-520 (1989).
Hyman, Carolyn, et al., "BDNF Is a Neurotrophic Factor for Dopaminergic Neurons of the Substantia Nigra," 350, Nature, pp. 230-232 (1991).
Jaeger, C.B., et al., "Growth of Tumor Cell Lines In Polymer Capsules: Ultrastructure of Encapsulated PC12 cells," 21, Journal of Neurocytology, pp. 469-480 (1992).
Jaeger, C.B., "Immunocytochemical Study of PC12 Cells Grafted to the Brain of Immature Rats," 59, Experimental Brain Research, pp. 615-624 (1985).
Jaeger, C.B., et al., "Polymer Encapsulated Dopaminergic Cell Lines as `Alternative Neural Grafts,`" 82, Progress in Brain Research, pp. 41-46 (1990).
Langston, J. William, et al., "Core Assessment Program for Intracerebral Transplanations (CAPIT),"7, Movement Disorders, pp. 2-13 (1992).
Lin, Leu-Fen, et al., "GDNF: A Glial Cell Line-Derived Neurotrophic Factor for Midbrain Dopaminergic Neurons," 260, Science, pp. 1130-1132 (1993).
Lindsay, Ronald, et al., "Neurotrophic Factors: From Molecule To Man," 17, TINS, pp. 182-190 (1994).
Winn, S.R., et al., "Behavioral Recovery Following Intrastriatal Implantation of Microencapsulated PC12 Cells," 113, Experimental Neurology, pp. 322-329 (1991); and.
Winn, S.R., et al., "Polymer-Encapsulated Cells Genetically Modified to Secrete Human Nerve Growth Factor Promote the Survival of Axotomized Septal Cholinergic Neurons," 9, Proc. Natl. Acad. Sci. USA, pp. 2324-2328 (1994).
Aebischer Patrick
Emerich Dwaine F.
Kordower Jeffrey H.
Coggins Wynn Wood
Cytotherapeutics, Inc.
Elrifi Ivor R.
Gring N. Kent
Levin Mintz
LandOfFree
Encapsulated PC12 cell transplants for treatment of Parkinson's does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Encapsulated PC12 cell transplants for treatment of Parkinson's , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Encapsulated PC12 cell transplants for treatment of Parkinson's will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1418936